Cardiovascular Journal of Africa

Volume 36, Issue 3

Evaluation of systemic immune inflammation and triglyceride/glucose indices in the development of no-reflow in ST elevation myocardial infarction

No-reflow is a phenomenon of unclear pathophysiology that occurs in approximately 5-10% of patients after primary percutaneous coronary intervention. Recently, the relationship between the systemic immune- inflammatory index (SII), which reflects inflammatory status, and the triglyceride-glucose index (TyG), which reflects insulin resistance, as well as heart disease and its complications, has...

The effect of cardiopulmonary bypass prime solution volume on blood transfusion: how do perfusionists manage fluid and what is the optimal prime solution volume?

During cardiopulmonary bypass (CPB), adequate prime solution allows pre-treatment of the tubing line, oxygenator and blood pump, evacuation of air from the arterial conduit, and appropriate blood dilution. However, the volume of prime solution may also affect the blood transfusion rate.

Relationship between ventricular arrhythmia and repolarisation parameters in patients with biventricular implantable cardioverter defibrillator

Depolarisation parameters obtained from electrocardiography are the basic parameters in cardiac resynchronisation treatment planning. This study examined the relationship of repolarisation parameters obtained before and after the procedure with ventricular arrhythmias and cardiovascular death in patients who underwent cardiac resynchronisation therapy (CRT)- implantable cardioverter...

Evaluating left ventricular diastolic function and chamber stiffness in heart failure: the impact of cardiac resynchronisation therapy on diastolic mechanics

Cardiac resynchronisation therapy (CRT) is a standard treatment for heart failure patients with ventricular conduction delay. While its benefits on left ventricular (LV) systolic function are well-established, the effects on LV diastolic mechanics remain controversial. This study aimed to investigate the interactions between CRT therapy, LV diastolic function, and LV chamber stiffness.